Ignite Creation Date:
2025-12-24 @ 9:58 PM
Ignite Modification Date:
2025-12-25 @ 7:35 PM
Study NCT ID:
NCT05866432
Status:
RECRUITING
Last Update Posted:
2025-09-25
First Post:
2023-05-10
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Phase II Study of Dato-DXd in Triple-negative Breast Cancer Patients With Newly Diagnosed or Progressing Brain Metastases
Sponsor:
Medical University of Vienna
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-07-01
Start Date Type:
ACTUAL
Primary Completion Date:
2026-05-23
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-05-23
Completion Date Type:
ESTIMATED
First Submit Date:
2023-05-10
First Submit QC Date:
None
Study First Post Date:
2023-05-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-22
Last Update Post Date:
2025-09-25
Last Update Post Date Type:
ESTIMATED